LESLIE PARTRIDGE: Open Payments
NPI 1043505266 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,662 in 79 payments from 14 companies in 2025. Trend: 2023 $270 · 2024 $89 · 2025 $1,662
Food & beverage: $1,595Education: $67
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $366 |
| ABBVIE INC. | 19 | $316 |
| Galderma Laboratories, L.P. | 5 | $178 |
| Regeneron Healthcare Solutions, Inc. | 8 | $169 |
| GENZYME CORPORATION | 3 | $154 |
| Janssen Biotech, Inc. | 4 | $139 |
| LEO Pharma Inc. | 4 | $87 |
| Amgen Inc. | 3 | $56 |
| Organon LLC | 2 | $44 |
| PFIZER INC. | 3 | $44 |
Products named: COSENTYX, DUPIXENT, SKYRIZI, NEMLUVIO, TREMFYA, RINVOQ, ADBRY, OTEZLA.
Industry payments across MS — which companies pay providers there.
